Gianni Bonadonna
- Pathology and Forensic Medicine top 0.05%
- Lymphoma Diagnosis and Treatment 118
- Breast Lesions and Carcinomas 29
- Oncology top 0.05%
- Cancer Treatment and Pharmacology 102
- HER2/EGFR in Cancer Research 23
- Cancer Research top 0.1%
- Breast Cancer Treatment Studies 107
- Hematology top 0.2%
- Genetics top 0.2%
- Chronic Lymphocytic Leukemia Research 36
-
- Lung Cancer Treatments and Mutations 60
-
- Chemotherapy-induced cardiotoxicity and mitigation 30
- Co-authors
- Pinuccia ValagussaArmando SantoroV. BonfanteUmberto VeronesiMarco BregniSalvatore SienaR ZucaliMilvia Zambetti
- Partner nations
- ItalyUnited StatesSwitzerland
In The Last Decade
Gianni Bonadonna
365 papers receiving 18.9k citations
Hit Papers
Peers
Comparison fields: 5 of 155
- Pathology and Forensic Medicine 7.5k
- Oncology 11.3k
- Cancer Research 5.9k
- Hematology 2.6k
- Genetics 2.2k
Countries citing papers authored by Gianni Bonadonna
This map shows the geographic impact of Gianni Bonadonna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gianni Bonadonna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gianni Bonadonna more than expected).
Fields of papers citing papers by Gianni Bonadonna
This network shows the impact of papers produced by Gianni Bonadonna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gianni Bonadonna. The network helps show where Gianni Bonadonna may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Gianni Bonadonna, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant chemotherapy for premenopausal breast cancer: a meta-analysis using quality-adjusted survival | 1995 | 3 |
| 2 | 1994 | 142 | |
| 3 | Flow cytometry to estimate circulating hematopoietic progenitors for autologous transplantation: comparative analysis of different CD34 monoclonal antibodies. | 1991 | 36 |
| 4 | Handbook of medical oncology | 1988 | 20 |
| 5 | Ex vivo depletion of human bone marrow T lymphocytes by soybean lectin fractionation followed by treatment with an anti-pan-T cell (CD5) ricin A- chain immunotoxin. | 1987 | 1 |
| 6 | 1987 | 6 | |
| 7 | 1980 | 151 | |
| 8 | Controlled study with BCNU vs. CCNU as adjuvant chemotherapy following surgery plus radiotherapy for glioblastoma multiforme. | 1979 | 43 |
| 9 | Improved 5-year survival in advanced Hodgkin's disease by combined modality approach | 1979 | 16 |
| 10 | Actual data on efficacy of surgical adjuvant chemotherapy with CMF in breast cancer. | 1978 | 1 |
| 11 | Combined chemotherapy-radiotherapy approach in stages IIB, IIIA and IIIB Hodgkin's disease | 1977 | 4 |
| 12 | MOPP vs MOPP plus ABVD in stage IV Hodgkin's disease | 1977 | 11 |
| 13 | Surgery and adjuvant chemotherapy in the treatment of operable breast cancer. | 1977 | 1 |
| 14 | STUDIO PILOTA CON DUE ASSOCIAZIONI CHEMIOTERAPICHE NEI CARCINOMI TESTICOLARI | 1976 | 0 |
| 15 | Controlled studies with bleomycin in solid tumors and lymphomas. | 1976 | 1 |
| 16 | 1976 | 98 | |
| 17 | Combination chemotherapy and radiotherapy in non-Hodgkin's lymphomata. | 1975 | 15 |
| 18 | 1972 | 87 | |
| 19 | 1969 | 174 | |
| 20 | PROPOSTA DI CLASSIFICAZIONE E TERAPIA DELLA MALATTIA DI HODGKIN. | 1965 | 3 |
About Gianni Bonadonna
Gianni Bonadonna is a scholar working on Pathology and Forensic Medicine, Cancer Research and Oncology, having authored 373 papers that have together received 20.2k indexed citations. Recurring topics across this work include Lymphoma Diagnosis and Treatment (118 papers), Breast Cancer Treatment Studies (107 papers), Cancer Treatment and Pharmacology (102 papers), Lung Cancer Treatments and Mutations (60 papers), Chronic Lymphocytic Leukemia Research (36 papers), Chemotherapy-induced cardiotoxicity and mitigation (30 papers), Breast Lesions and Carcinomas (29 papers) and HER2/EGFR in Cancer Research (23 papers). The work is most often cited by research in Pathology and Forensic Medicine (7.5k citations), Oncology (11.3k citations) and Cancer Research (5.9k citations). Gianni Bonadonna has collaborated with scholars based in Italy, United States and Switzerland. Frequent co-authors include Pinuccia Valagussa, Armando Santoro, V. Bonfante, Umberto Veronesi, Marco Bregni, Salvatore Siena, R Zucali, Milvia Zambetti, S. Monfardini and Mario De Lena. Their work appears in journals such as New England Journal of Medicine, The Lancet and JAMA.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.